Needle-free syringes have developed rapidly in recent years. In China, Kuaishuer's needle-free syringe is an example. Last year, it became the first Chinese independent intellectual property needle-free drug delivery system to successfully debut at ADA (The American Diabetes Association), and this year Won the "Top Ten Medical Devices Award" at the 12th Healthy China Forum. With the continuous innovation of needle-free injection technology, it may be a foregone conclusion that needle-free syringes will replace traditional insulin syringes with needles in the near future.
That's the trend, but that doesn't mean giving up on syringes with needles. Looking at the circle of diabetes friends, many people with diabetes who use insulin pens are hesitant to switch to needle-free syringes. After all, the price is higher, and they are worried that they will not get used to it. There are also some type 2 diabetes patients who are not afraid of needles. After intensive insulin treatment, you can take oral medicine. It will be over after you tolerate it. There is no need to spend so much money to replace it with a needleless syringe. People with diabetes who have used needleless syringes have always recommended it. All kinds of news are flying all over the sky, and I am afraid that many novices are confused and don't know whether to choose needles or no needles. Don't be confused, just follow the editor and take a look below, maybe it will become clear.
one. insulin pen
advantage:
1. The operation is simple. Diabetic patients can quickly master the usage skills under the guidance of medical staff. It is easy to learn and use. It is relatively compact and easy to carry when traveling, and can also hide the injection process to avoid embarrassment;
2. The needle is small, usually 4-5mm, which can reduce the pain of injection;
3. It can avoid diabetic ketoacidosis caused by equipment problems.
4. Lower cost
insulin pen
shortcoming:
1. The insulin pen injects at least 0.5 units of insulin and cannot achieve microinjection;
2. The needle needs to be changed every time. If you do not change the needle or inject in one place for a long time, it will easily lead to subcutaneous induration, which will affect the absorption of insulin and maintain blood sugar stability;
3. Long-term acupuncture will damage the skin tissue, causing needle holes and pain.
4. Diabetic patients who are afraid of needles or faint from needles will have a great psychological burden, and improper operation may easily lead to needle breakage, infection, etc.
two. Needleless syringe
advantage:
1. Avoiding pain reduces the resistance of diabetic patients such as fear of needles, making them more willing to cooperate with treatment, which greatly improves treatment compliance;
2. The needle will not break and will not puncture the skin, ensuring aseptic operation to a greater extent and reducing the risk of infection;
3. Needle-free injection enters the subcutaneous tissue in the form of a spray and is diffusely distributed, making the liquid contact area larger, absorbing more efficiently and evenly, and controlling blood sugar better;
4. No subcutaneous induration will occur due to repeated injections
Needleless syringe
Disadvantages: Compared with insulin pens, they are more expensive and larger, making them less convenient to carry. The domestic price is about 4,000, and the imported price is about 5,000.
Therefore, no matter which one you choose, you must consider it carefully based on your own actual situation.
In the realm of modern diabetes management, innovations like Kuaishuer's needle-free syringe in China are reshaping patient experiences. As we delve into the ongoing evolution of injection technologies, it's crucial to weigh the benefits and drawbacks of traditional insulin delivery methods against the promising advancements, such as the novolog flexpen cost and its implications in the decision-making process.
The novolog flexpen, a well-known insulin delivery device, offers convenience and precision, but its cost dynamics often come into play when discussing alternatives like the cutting-edge needle-free systems. While traditional insulin pens like the Flexpen aim to simplify administration with features like minimal pain due to smaller needles (approximately 4-5mm) and cost-effectiveness, they still entail recurring expenses like replacing needles and potential issues like subcutaneous nodules from repeated injections.
On the other hand, the revolutionary needle-free syringes, despite their higher upfront investment—estimated domestically around 4,000 yuan and imported options costing roughly 5,000 yuan—promise enhanced user experience by eliminating needle phobia, reducing pain, and ensuring aseptic conditions. Their unique spray-based injection mechanism promotes efficient insulin absorption, contributing to better blood sugar control without the formation of injection site lumps.
When contemplating a shift from conventional insulin pens to novel needle-free systems, the discussion inevitably circles back to the novolog flexpen cost versus the long-term benefits of investing in advanced, pain-free technology. For individuals managing their diabetes with intensive insulin therapy, factoring in the overall cost of healthcare, including potential complications from traditional injections, can make the case for considering the initial outlay for a needle-free syringe more compelling.
For those who are budget-conscious or whose diabetes management allows for flexibility, sticking with traditional insulin pens like the novolog flexpen might seem financially prudent. However, for those seeking to optimize their quality of life by alleviating the discomfort and anxiety associated with needles, closely examining the total cost of ownership, including the emotional and physical wellbeing aspects alongside the novolog flexpen cost, becomes vital.
Ultimately, the choice between conventional insulin pens and innovative needle-free devices like Kuaishuer's, which made a groundbreaking appearance at ADA, hinges on personal preferences, financial considerations, and the specific needs of each individual's diabetes management regimen. As technology advances and potentially drives down the costs of needle-free options, the horizon for accessible, pain-free insulin delivery widens, making the future of diabetes care an exciting prospect to watch.